ADVANCED SOLID TUMORS

This early-stage clinical trial is testing a new drug called VIB305 in people with advanced solid tumors that have stopped responding to standard treatments. The study aims to find the safest and most effective dose and to see if the drug can help control the cancer. It will enro…

This is the first human study of an experimental drug called ASP1002 for people with advanced solid tumors that have spread. The main goals are to find a safe dose and check for side effects. The study will enroll adults whose cancers have high levels of a protein called claudin-…

This is the first human study of an experimental drug called BTM-3566 for adults with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find safe dose levels and see how the drug behaves in the body. Participants will take the drug i…

This study is testing the safety and initial effectiveness of a new two-drug combination (YL201 plus ivonescimab) for people with advanced solid tumors, including specific types of lung cancer. The main goals are to find the safest dose and see if the treatment can shrink tumors.…

This is the first human study of an experimental cancer drug called M7437, designed to target specific proteins found on cancer cells. The trial aims to find a safe dose and see if the drug shows early signs of effectiveness in people with advanced solid tumors that have stopped …

This early-stage study aims to find a safe and effective dose of a new drug called EIK1005 for people with advanced solid tumors that have spread or cannot be removed by surgery. Researchers will test EIK1005 by itself and combined with an existing immunotherapy drug (pembrolizum…

This is an early-stage study to test the safety and side effects of a new drug called MK-0472 for people with advanced or metastatic solid tumors. Researchers will give the drug alone and in combination with other cancer therapies to about 178 participants. The main goal is to fi…

This early-stage trial is testing a new radioactive drug called HRS-6768 in patients with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find a safe and effective dose and to see how the drug moves through and affects the body. Re…

This clinical trial is testing an experimental drug called GFH375 for people with advanced solid tumors that have a specific genetic mutation called KRAS G12D. The study aims to determine if the drug is safe, how it moves through the body, and if it can help shrink tumors. It wil…

This study is testing a new drug called MK-3120 in people with advanced solid tumors that have spread and cannot be removed by surgery. The main goals are to check if the drug is safe and if people can tolerate it, while also seeing if it helps shrink tumors or slow cancer growth…

This study is testing a new investigational drug called marlotamig, both by itself and in combination with an existing immunotherapy drug (cemiplimab), for people with advanced solid tumors. The main goals are to find a safe and effective dose and to see how well the treatments w…

This early-stage trial is testing a new drug called TEV-56278, both alone and combined with an existing immunotherapy (pembrolizumab), for people with advanced solid tumors that have stopped responding to standard treatments. The study aims to find safe doses and see if the drug …

This is an early-stage study to test the safety and find the right dose of a new drug called ABX-001. It will be given to adults with advanced solid tumors that have stopped responding to standard treatments. The study will test the drug by itself and also in combination with an …

This is a very early study to test the safety and find the right dose of a new radioactive drug called 177Lu-RAD202 for people with advanced HER2-positive solid tumors. The study will enroll about 30 adults whose cancer has progressed after standard treatments. First, a small 'im…

This is the first human trial of a new cancer drug called BMS-986484. Researchers are testing it alone and combined with an existing immunotherapy (nivolumab) in 213 people with advanced solid tumors, including lung, pancreatic, and colorectal cancers. The main goal is to find sa…

This is the first study in humans of an experimental drug called MGC028 for people with advanced solid tumors that have stopped responding to standard treatments. Researchers will test increasing doses in about 124 participants to find the highest safe amount and check for side e…

This early-stage study is testing an experimental drug called SHR-A1904 in people with advanced solid tumors, specifically gastric, pancreatic, and other cancers that have stopped responding to standard treatments. The main goals are to find the safest and most effective dose, ch…

This study is testing a new oral medication called RMC-6236 in adults with advanced solid tumors, including lung, colorectal, and pancreatic cancers, that have specific RAS mutations. The main goals are to find a safe and effective dose and to see if the drug can help control the…

This is a first-in-human study to test the safety and find the right dose of a new drug called FS-8002 in people with advanced solid tumors. It will enroll 66 patients whose cancer has progressed despite standard treatments. The main goal is to see how much of the drug the body c…

This is the first time a new drug called GenSci139 is being tested in people. The study aims to find a safe dose and see how the body processes the drug in patients with advanced solid tumors that have spread or cannot be removed by surgery. Researchers will also look for early s…

This study is testing a new type of cell therapy for people with advanced solid tumors that have not responded to standard treatments. Doctors take a patient's own immune cells from a tumor sample, modify them in the lab to potentially work better, and then infuse them back into …

This is the first human study of an experimental cancer drug called SKB500. Researchers want to find out if it's safe, how the body processes it, and if it shows any signs of fighting cancer. The study will enroll 180 adults with advanced solid tumors that haven't responded to st…

This study is testing new combinations of experimental drugs for people with advanced solid tumors that have specific RAS mutations. Researchers want to see if combining a new type of drug called a RAS(ON) inhibitor with another cancer drug called ivonescimab is safe and can help…

This is the first study in people to test a new drug called SKB445 for patients with advanced solid tumors that have not responded to standard treatments. The main goals are to find a safe dose and see how the body processes the drug. Researchers will also look for early signs th…

This is a first-in-human study to test the safety and early effectiveness of a new oral drug called VVD-133214. It will be given alone and in combination with an existing immunotherapy (pembrolizumab) to people with advanced solid tumors that have specific genetic features known …

This is the first study in people to test a new oral drug called ATX-295, which works by blocking a specific protein that helps cancer cells divide. The main goals are to find a safe dose and see how the body processes the drug in about 90 patients with advanced solid tumors, inc…

This is the first time researchers are testing the experimental drug SKB518 in people. The study aims to find a safe dose and see how the body handles the drug in 150 adults with advanced solid tumors that have stopped responding to standard treatments. The main goal is to check …

This early-stage trial is testing whether a new drug called HRS-4642, when combined with other cancer treatments, is safe and effective for people with advanced solid tumors that have a specific genetic change (KRAS G12D mutation). The study aims to find the best dose and see if …

This study is testing a new two-part treatment for advanced solid tumors that have not responded to standard therapies. It combines a specially engineered virus designed to attack cancer cells with a drug that helps the immune system fight cancer. The main goals are to see if thi…

This early-stage study is testing the safety and initial effects of a new drug called SYN818 when given with an existing cancer drug, olaparib. It is for adults with advanced or metastatic solid tumors (like ovarian or breast cancer) that have specific genetic changes (BRCA mutat…

This study is testing a new drug called SHR-1826, given alongside other cancer treatments, for people with advanced solid tumors. The main goals are to find a safe dose, see how well the body tolerates it, and measure if it helps shrink tumors. Researchers will enroll about 876 a…

This is the first study in people to test a new potential cancer drug called BG-C477. The main goal is to find out if the drug is safe, what side effects it causes, and what dose to use. It will be tested alone and combined with other cancer treatments in adults with advanced sol…

This is the first human study of an experimental drug called CKD-512. It aims to find a safe dose and see if the drug, given alone or with an existing immunotherapy (pembrolizumab), can help control advanced solid tumors. The study is for people whose cancer has continued to grow…

This is the first study in people to test an experimental drug called SIM0505 for advanced solid tumors. It aims to find a safe dose and see early signs of whether the drug can shrink tumors. The study is for adults with specific advanced cancers, like certain ovarian, kidney, ut…

This is the first time a new drug called ALK201 is being tested in people. The study aims to find a safe dose and see if it can help shrink tumors in adults with advanced solid cancers that have spread. Researchers will also check how the drug moves through the body and look for …

This early-stage study is testing a new drug called YL205 in people with advanced solid tumors that have spread or cannot be removed by surgery. The main goals are to find a safe dose, see how the body processes the drug, and get a first look at whether it helps shrink tumors. Th…

This early-phase study is testing the safety and effectiveness of a personalized immune cell therapy for adults with advanced solid tumors that have not responded to standard treatments. Doctors take a patient's own tumor-fighting immune cells, grow large numbers of them in a lab…

This early-stage study is testing a new oral drug called ASP1570 in adults with advanced solid tumors that have spread or cannot be removed by surgery. The main goals are to find a safe dose and see how well the drug is tolerated, both by itself and when combined with other stand…

This is the first study in people to test a new oral drug called VVD-159642, which is designed to block specific cancer growth signals. It will enroll about 220 adults with advanced solid tumors that have spread or cannot be removed by surgery. The main goals are to find a safe d…

This is an early-stage study testing a new drug called Hemay181 in patients with advanced solid tumors that have stopped responding to standard treatments. The main goals are to see if the drug is safe and if it can shrink tumors. The study will enroll about 24 patients who have …

This early-stage study is testing a new drug called GW5282 in adults with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find a safe dose and see if the drug can shrink tumors. Researchers will first test increasing doses to check…

This is the first study in people to test a new drug called GenSci143 for advanced solid tumors. The main goals are to find a safe dose and see how the body processes the drug. It is for adults whose cancer has continued to grow despite standard treatments or who have no other tr…

This is the first study in people testing a new drug called PHST001 for adults with advanced solid tumors that have returned or stopped responding to all available standard treatments. The main goals are to find a safe dose and see how the body handles the drug. Researchers will …

This study is testing a new drug called BMS-986482 to see if it is safe and effective for treating advanced solid tumors. It will involve about 413 adults whose cancer has progressed despite standard treatments. The drug will be tested both by itself and in combination with other…

This is an early safety study to see if a new drug called AT1019 is safe when given with targeted radiation and an immunotherapy drug for people with advanced solid tumors. The main goal is to find the highest dose of AT1019 that patients can tolerate without severe side effects.…

This is the first study in humans testing PAS-004, an oral medication designed to target specific genetic mutations found in advanced solid tumors. The main goal is to find a safe dose and understand side effects in 48 adults whose cancers have progressed despite standard treatme…

This study is testing a new drug called MB0151 in adults with advanced solid tumors that have progressed after standard treatments. The main goals are to find a safe dose and see if the drug can shrink or control tumors. The trial is open to people with specific cancers, includin…

This study is testing a new oral drug called SPR1020 in adults with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find a safe dose and see how the body processes the drug. Researchers hope this new, more targeted drug may shrink …

This early-stage study is testing a new drug called RMC-5127 in adults with advanced cancers that have a specific genetic change called KRAS G12V. The main goals are to find a safe dose and see how the body processes the drug, both when given alone and when combined with other ca…

This study is testing whether a new drug called SPH4336 works better alone or when combined with another drug, cadonilimab, for people with advanced solid tumors that can't be removed by surgery. The main goal is to see if the treatment can slow or stop cancer growth and is safe …

This is the first study in humans of a new drug called INCA33890 for people with advanced or spreading solid tumors. Researchers will test different doses in 408 participants to find the safest amount and see how the body processes the drug. The main goals are to understand side …

This is an early-stage study to test the safety and find the right dose of a new oral drug called ZX-8177. It will involve about 80 Chinese adults with advanced solid tumors that have not responded to standard treatments. The main goals are to see how the body handles the drug an…

This early-stage clinical trial is testing a new drug called MRG006A in people with advanced solid tumors that have stopped responding to standard treatments. The study aims to find the safest and most effective dose and see if the drug can help shrink tumors. Researchers will en…

This is the first study in humans testing a new cancer drug called TGW101. Researchers will give the drug to 50 patients with advanced solid tumors to check if it's safe and to find the right dose. They'll also look for early signs that the drug might help shrink tumors in cancer…

This is the first human study of a new drug called HS-20122 for people with advanced solid tumors that have stopped responding to standard treatments. Researchers will test different doses to find the safest amount and see how the drug moves through the body. The study will also …

This study is testing a new drug called YL202, given alongside other cancer treatments, to see if it is safe and effective for people with advanced solid tumors like breast or lung cancer. The main goals are to find the safest dose and see if the treatment helps shrink tumors. It…

This is the first study in people for a new drug called OKI-219, designed to target a specific genetic mutation (PI3KαH1047R) found in some advanced cancers. The main goals are to find a safe dose and see how the body handles the drug, both alone and combined with other cancer tr…

This early-stage study is testing the safety and initial effects of an experimental cell therapy called GK01 in patients with advanced lung or esophageal cancer who have no other treatment options left. Researchers will give GK01 to 10 patients and closely monitor for side effect…

This study is testing a new drug called SHR-3821 in people with advanced solid tumors to see if it's safe and how the body processes it. Researchers will enroll 162 adults with various advanced cancers to determine the right dose and look for early signs of effectiveness. This is…

This is the first-ever study in people of an experimental drug called metarrestin. The main goals are to find a safe dose and see if it can shrink tumors. It is for adults and teenagers (12+) with advanced solid tumors that have spread and have not been cured by standard treatmen…

This is the first study in people to test a new experimental cancer drug called AK146D1. The main goals are to find a safe dose and see how the body processes the drug in up to 200 adults with advanced solid tumors that have progressed after standard treatments. Researchers will …

This study allows people with advanced solid tumors and a specific KRAS gene mutation to continue taking an experimental drug combination if they are already benefiting from it in a previous Amgen trial. The main goal is to check the long-term safety and side effects of continuin…

This study is testing a new medicine, SNV4818, for people with advanced solid tumors that have a specific genetic change (PIK3CA mutation). The main goals are to find the safest and most effective dose of SNV4818, both by itself and when combined with other cancer drugs. Research…

This study is testing a new experimental cancer drug called LCB84. It is designed to target and deliver medicine directly to cancer cells in patients with advanced solid tumors that have stopped responding to standard treatments. The trial will first test the drug alone to find a…

This early-stage study is testing a new drug called SBO-154 in people with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find a safe dose and see how well the body tolerates the drug. Researchers will also check for early signs t…

This is a first-in-human study to test the safety and find the right dose of a new drug called SIBP-A19 for people with advanced solid tumors. It will enroll about 156 adults whose cancer has progressed despite standard treatments. The main goal is to see how much of the drug the…

This is the first study in people to test a new drug called BAT8008 for advanced solid tumors. The main goal is to find a safe dose and understand how the drug moves through the body in patients whose cancer has progressed after standard treatments. Researchers will also look for…

This study aims to see if matching existing cancer drugs to the specific genetic changes found in a person's tumor can help control advanced cancers. It is for adults with certain advanced solid tumors, lymphoma, or multiple myeloma who have run out of standard treatment options.…

This study is testing a new drug called DT-7012 for people with advanced solid tumors that have spread or returned after other treatments. The main goals are to find a safe dose and see if the drug, given alone or with an immunotherapy, can help control the cancer. It is an early…

This is a first-in-human study testing a new oral drug called HW071021 for people with advanced solid tumors that have stopped responding to standard treatments. The trial aims to find a safe dose and see how the body processes the drug, while also checking for early signs that i…

This study is testing whether combining two drugs can help people with aggressive cancers that have stopped responding to standard treatments. It focuses on small cell lung cancer and other cancers with specific genetic weaknesses that have become resistant to previous drugs. The…

This early-stage study is testing a new way to give the cancer drug rilvegostomig—as a simple injection under the skin instead of through an IV. It aims to find the right injection dose that gives similar drug levels in the body as the IV method and to check its safety. The study…

This early-stage study is testing a new oral tablet called WJ22096 in patients with advanced solid tumors, like lung, colorectal, and pancreatic cancer, who have no other standard treatment options. The main goals are to find a safe dose, see how the body processes the drug, and …

This early-stage study is testing a new experimental drug called JNJ-87890387 in people with advanced solid tumors that have spread or cannot be surgically removed. The main goals are to find a safe dose and understand how the body handles the drug. The trial is enrolling 200 adu…

This early-stage study is testing a new oral drug called BMS-986504 in Japanese and Chinese patients with advanced solid tumors that have a specific genetic deletion called MTAP. The main goals are to check how safe the drug is, how well patients tolerate it, and how the drug mov…

This is an early-stage study testing a new experimental drug called CS2009 in people with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find a safe dose and see if the drug shows any early signs of fighting the cancer. The drug i…

This study is testing a new drug called CM518D1 in people with advanced solid tumors that have spread. Researchers want to find the safest dose and see if the drug helps shrink tumors. The trial will enroll 434 adults to check for side effects and measure how well the treatment w…

This is the first study in people to test a new drug called GenSci140 for advanced solid tumors, like ovarian cancer. The main goals are to find a safe dose, understand how the body processes the drug, and see if it shows any early signs of helping to control the cancer. The stud…

This study is testing a new drug called TUB-030 in adults with advanced solid cancers that have not responded to other treatments. The main goals are to find the safest dose and see if the drug helps control the cancer. It will focus on specific cancers like head and neck cancer …

This is a first-in-human study to test the safety and find the right dose of a new investigational drug called DB-1311 for people with advanced solid tumors that have progressed after standard treatments. The trial will enroll adults with various cancers to see how their bodies h…

This study is testing a new oral drug called JAB-23E73 for adults with advanced solid tumors that have a specific genetic change called a KRAS alteration. The main goals are to find a safe and effective dose and to see if the drug can shrink tumors. It is for people whose cancer …

This is a first-in-human study to test a new oral drug called FORX-428 in adults with advanced solid tumors that have specific genetic mutations, like BRCA1/2. The main goals are to find a safe dose and see how the body processes the drug. The study will enroll about 40 people wh…

This is the first study in humans to test a new experimental drug called HDM2006. It aims to find a safe dose and see early signs of whether it can help control advanced solid tumors in patients who have already tried standard treatments without success. The study will enroll abo…

This is the first study in people testing an experimental pill called TYRA-430. It aims to find a safe dose and see if it can help control advanced liver cancer and other solid tumors that have specific genetic changes in the FGF/FGFR pathway. The study will enroll about 100 adul…

This is the first study in people testing a new oral medication called GEN-725 for advanced solid tumors that have progressed after standard treatments. The main goals are to find a safe dose, see how the drug moves through the body, and check for any early signs that it might he…

This early-stage trial is testing a new drug called AMT-253 for people with advanced melanoma or other solid tumors that have spread and cannot be removed by surgery. The study aims to find a safe dose and see if the drug can shrink tumors in patients who have already tried stand…

This early-stage study is testing a new treatment called JNJ-87704916, which is a modified virus designed to infect and kill cancer cells. It will be injected directly into tumors of patients with advanced solid tumors who have run out of standard treatment options. The main goal…

This is the first study in people to test a new oral medication called JMKX005425. It aims to find a safe dose and see if it helps control advanced solid tumors that have specific genetic markers (MSI-H or dMMR). The study will enroll about 102 patients to check for side effects …

This early-stage trial is testing a new oral medication called ST-01156 in adults with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find a safe dose and see how the body processes the drug. Researchers will also look for early s…

This early-stage clinical trial is testing a new drug called WEF-001 in people with advanced cancers that have a specific KRAS gene mutation. The study aims to find a safe dose and see if the drug can shrink tumors in cancers like pancreatic, colorectal, and lung cancer that have…

This early-stage trial is testing the safety and effectiveness of an experimental mRNA cancer vaccine called mRNA-4359. It will be given alone and combined with approved immunotherapy drugs to 361 adults with advanced solid tumors like melanoma and lung cancer. The main goals are…

This early-stage study is testing a new drug called OTP-01 in adults with advanced solid tumors that have progressed after standard treatments. The main goals are to find the safest and most effective dose, understand how the body processes the drug, and see if it can shrink tumo…

This is the first study in people testing a new cancer drug called HRS-3802. It aims to find a safe dose and see how the body handles the drug in 100 adults with advanced solid tumors that have not responded to standard treatments. Researchers will monitor for side effects and ch…

This is an early-stage study to test the safety and find the right dose of a new drug called ACR246 for people with advanced solid tumors. It will involve about 77 adults whose cancer has continued to grow despite standard treatments. The main goal is to see how well the drug is …

This is the first study in people to test a new cancer drug called YL211. It aims to find a safe dose and see how the body processes the drug in patients with advanced solid tumors that have not responded to standard treatments. The main goals are to check for side effects and se…

This early-stage clinical trial is testing a new experimental drug called BMS-986490, both alone and combined with an existing cancer drug (bevacizumab), for people with advanced solid tumors that have stopped responding to standard treatments. The study aims to determine if the …

This early-stage trial is testing a new oral medication called ALTA3263 in adults with advanced solid tumors that have specific KRAS mutations. The study aims to find a safe dose and see how the body processes the drug, while also checking for early signs that it might help contr…

This is the first study in people testing a new experimental cancer drug called PHN-012. It aims to find a safe dose and see if it can shrink tumors in patients with advanced colon, lung, or pancreatic cancer who have no other standard treatments left. The study will enroll about…

This study is testing an oral pill called BAY2927088 for people with advanced solid tumors that have a specific genetic change (HER2 mutation). The goal is to see if the pill can shrink tumors and control the cancer's growth. About 111 adults with cancers like colorectal, breast,…

This study is testing a new drug called FL115 when given together with an existing immunotherapy drug (Sintilimab) for people with advanced solid tumors. The main goals are to find a safe dose and see if the combination shows early signs of helping to control the cancer. About 13…

This early-phase study is testing the safety and initial effectiveness of a new type of cell therapy called Meta10-TIL for people with advanced solid tumors that have stopped responding to standard treatments. Doctors take a patient's own immune cells from their tumor, modify the…

This is the first time a new oral drug called SIGX1094R is being tested in people. The main goal is to find a safe dose and understand its side effects in patients with advanced solid tumors that have stopped responding to standard treatments. Researchers will also check if takin…

This study is testing an experimental daily pill called ABP1011T for people with advanced solid tumors, like certain lung, esophageal, and cervical cancers, who have already tried and stopped responding to standard treatments. The main goal is to see if the pill can shrink tumors…

This study is testing a new drug called ASKG915 in people with advanced solid tumors that haven't responded to standard treatments. Researchers want to find the safest and most effective dose, first by giving the drug alone and then by combining it with standard cancer treatments…

This is the first study in people to test a new cancer drug called FID-022. It aims to find a safe dose and see how the body processes the drug in up to 24 adults with advanced solid tumors that have no standard curative treatments. The drug is given through an IV and contains ch…

This early-stage study is testing a new drug called MK-1084 (calderasib) in people with advanced solid tumors that have a specific genetic change called KRAS G12C. The main goals are to find safe doses and see how the body processes the drug, both when given alone and combined wi…

This trial is testing whether combining a drug called sirolimus with several newer antibody-drug conjugates (ADCs) is safe and effective for people with advanced solid tumors that have spread or can't be removed by surgery. Researchers will enroll about 444 patients to find the b…

This is the first human study of an experimental drug called VVD-130037 for people with advanced solid tumors that have stopped responding to standard treatments. The trial aims to find the safest dose and see how the drug affects the body, both alone and when combined with other…

This is a first-in-human study to test the safety and early signs of effectiveness of a new cancer drug called ZW191. It is for adults with advanced solid tumors, such as ovarian, endometrial, and non-small cell lung cancers, that have spread or returned. The main goal is to find…

This early-stage study is testing a new experimental drug called ETX-636 in people with advanced solid tumors that have a specific genetic change (PIK3CA mutation). The trial will first check if the drug is safe and find the right dose, both when given alone and when combined wit…

This early-stage study is testing a new, experimental immunotherapy drug called REGN10597, both by itself and combined with an existing drug (cemiplimab), in people with advanced solid tumors like melanoma and kidney cancer. The main goals are to find a safe dose and see if the t…

This is the first human trial testing a new antibody called GEN1079 for people with advanced solid tumors that have spread or cannot be removed by surgery. The study aims to find safe doses and see if the treatment shows early signs of helping control cancer. About 121 participan…

This study is testing a new drug called SKB315 for people with advanced solid tumors that have a specific protein called Claudin18.2. The main goals are to find a safe dose and see if the drug can help shrink tumors. It will involve about 246 participants whose cancer has not res…

This is the first time researchers are testing the experimental drug FP008 in people with advanced solid tumors. The study aims to find a safe dose and see how the body processes the drug. It will also check if the drug shows any early signs of helping control cancer in patients …

This study is testing if wearing a medical compression stocking on one foot during cancer treatment can prevent nerve damage, a common and painful side effect. The trial involves 58 patients with advanced cancers who are receiving a specific type of targeted drug therapy. Researc…

This early-stage study aims to understand how the cancer drug pralatrexate is processed by the body in people with varying degrees of liver impairment. It will involve about 24 adults with advanced solid tumors or blood cancers. The main goal is to measure drug levels in the bloo…

This early-stage study aims to understand how a new oral cancer drug, rezatapopt, interacts with four common medications (metformin, rosuvastatin, repaglinide, and midazolam). It will enroll about 14 adults with advanced solid tumors that have a specific genetic mutation called T…

This study aims to learn from real-world experience by observing how well FDA-approved targeted cancer drugs work for patients with advanced solid tumors, lymphoma, or multiple myeloma. It enrolls over 4,000 patients whose tumors have specific genetic changes that suggest a drug …

This early-stage study aims to understand how a common antifungal drug (itraconazole) affects the way the body processes a new experimental cancer drug (HS-20093). It involves 18 adults with advanced solid tumors who have no other standard treatment options. The main goal is to m…